Experiences with Neurofibromatosis

This page shows detailed information about a disease such as statistics, patient reviews and related articles.

Also known as:
---
ICD10/11 Code: Q85.0
ICD10/11 Group: Q00-Q99, Congenital malformations, deformations and chromosomal abnormalities
reviews
Neurofibromatosis
Also known as: ---
ICD10/11 Code: Q85.0, ICD10/11 Group: Q00-Q99, Congenital malformations, deformations and chromosomal abnormalities

Read our patient's reviews about Neurofibromatosis

No recent reviews to display.

We are sorry but at the moment we do not have any recent reviews to show you. Contribute to this platform and share your experience with other patients. Choose one of the options below.


Most used drugs for this disease


Reviews from the most used drugs for this disease

Levocetirizine

4/17/2017 | | 42moderated by Charlotte
Levocetirizine (5mg) for neurofibromatosis

I've had this condition since I was 18, always having something or other taken out at the hospital. I was looking online to see if there was anything I could do about it and I found an article that I asked the doctor about. And no sooner said than done. It wasn't getting any worse for me, the lumps and bumps were getting less visible. I'm going to carry on taking them because if I don't they ju...
> read full review...

Most reviewed diseases


The content on this page is user-generated content, read and revised before approval to comply with our standards for a condition review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.